ArticleAntiviral research2021

A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge.

Scott Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.